161,443 Shares in Astera Labs, Inc. $ALAB Acquired by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 161,443 shares of the company’s stock, valued at approximately $77,980,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.09% of Astera Labs at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of ALAB. Royal Bank of Canada grew its position in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC boosted its stake in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC boosted its stake in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP boosted its stake in Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. grew its position in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $284.97 on Monday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a fifty day moving average of $352.70 and a 200-day moving average of $245.57. The stock has a market capitalization of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ALAB. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Susquehanna boosted their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Bank of America boosted their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a research note on Monday, August 17th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.